Wales Pharma is a growing pharmaceutical company offering a diversified portfolio of healthcare products across multiple therapeutic segments, including products relevant to orthopedic care, pain management, and bone and joint healthcare. The company specializes in manufacturing premium-quality pharmaceutical formulations, particularly injectable products, and operates with a focus on quality, safety, and regulatory compliance.

Its product portfolio includes tablets, capsules, softgel capsules, injections, IV fluids, syrups, eye and ear drops, ointments, and creams. The available product range includes formulations such as calcium and vitamin combinations, L-carnitine-based products, analgesic and anti-inflammatory formulations, and other products relevant to different therapeutic requirements.

Wales Pharma also provides PCD Pharma Franchise and Third Party Pharma Manufacturing services, helping pharmaceutical businesses and distributors access a broad range of healthcare products. Its manufacturing infrastructure focuses particularly on sterile injectable formulations, while its wider product portfolio enables business partners to serve multiple healthcare segments.

With an emphasis on quality, advanced manufacturing technology, professional expertise, and reliable pharmaceutical supply, Wales Pharma continues to expand its presence in the Indian pharmaceutical market. Its diversified portfolio and orthopedic-relevant formulations make it a suitable company to feature in an Ortho Products Companies category.